3-Benzyl-6-benzylamino-1-methyl-5-nitro-1,2,3,4-tetrahydropyrimidine

被引：0

作者：

Kannan, M. ^{[1
]}

Manivel, P. ^{[1
]}

Sarathbabu, M. ^{[2
]}

Sathishkumar, R. ^{[3
]}

Rao, H. Surya Prakash ^{[2
]}

Krishna, R. ^{[1
]}

机构：

[1] Pondicherry Univ, Ctr Bioinformat, Pondicherry 605014, India

[2] Pondicherry Univ, Dept Chem, Pondicherry 605014, India

[3] Indian Inst Sci, Solid State & Struct Chem Unit, Bangalore 560012, Karnataka, India

来源：

ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE | 2010年 / 66卷

关键词：

Data-to-parameter ratio = 17.5; Mean σ(C-C) = 0.004 Å; R factor = 0.067; Single-crystal X-ray study; T = 292 K; WR factor = 0.160;

D O I：

10.1107/S160053681000348X

中图分类号：

O7 [晶体学];

学科分类号：

0702 ; 070205 ; 0703 ; 080501 ;

摘要：

In the title compound, C19H22N4O2, the tetrahydropyrimidine ring adopts an envelope conformation (with the N atom connected to the benzyl group representing the flap). This benzyl group occupies a quasi-axial position. The two benzyl groups lie over the tetrahydropyridimidine ring. The amino group is a hydrogen-bond donor to the nitro group.

引用

页码：O515 / U4095

页数：11

共 9 条

[1]

[Anonymous], 2009, CRYSALIS CCD CRYSALI

[2] DIHYDROPYRIMIDINE CALCIUM-CHANNEL BLOCKERS .3. 3-CARBAMOYL-4-ARYL-1,2,3,4-TETRAHYDRO-6-METHYL-5-PYRIMIDINECARBOXYLIC ACID-ESTERS AS ORALLY EFFECTIVE ANTIHYPERTENSIVE AGENTS [J].

ATWAL, KS ;

SWANSON, BN ;

UNGER, SE ;

FLOYD, DM ;

MORELAND, S ;

HEDBERG, A ;

OREILLY, BC .

JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (02) :806-811

[3]

CHANDA K, 2004, MOLBANK, pM367

[4] GENERAL DEFINITION OF RING PUCKERING COORDINATES [J].

CREMER, D ;

POPLE, JA .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1975, 97 (06) :1354-1358

[5]

Farrugia L.J., 1997, J. Appl. Crystallogr., V30, P565, DOI [10.1107/S0021889897003117, DOI 10.1107/S0021889897003117]

[6] Design and synthesis of a conformationally rigid mimic of the dihydropyrimidine calcium channel modulator SQ 32,926 [J].

Jauk, B ;

Pernat, T ;

Kappe, CO .

MOLECULES, 2000, 5 (03) :227-239

[7] Synthesis and biological characterization of 1,4,5,6-tetrahydropyrimidine and 2-amino-3,4,5,6-tetrahydropyridine derivatives as selective m1 agonists [J].

Messer, WS ;

Abuh, YF ;

Liu, Y ;

Periyasamy, S ;

Ngur, DO ;

Edgar, MAN ;

ElAssadi, AA ;

Sbeih, S ;

Dunbar, PG ;

Roknich, S ;

Rho, T ;

Fang, Z ;

Ojo, B ;

Zhang, H ;

Huzl, JJ ;

Nagy, PI .

JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (08) :1230-1246

[8] A short history of SHELX [J].

Sheldrick, George M. .

ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 :112-122

[9] Structure validation in chemical crystallography [J].

Spek, Anthony L. .

ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2009, 65 :148-155

← 1 →